KURA Kura Oncology Posts $0.92/Share Q4 Loss as KOMZIFTI Launch Delivers $2.1M in Initial Revenue 2 weeks ago Kura Oncology reports wider Q4 loss of $0.92/share as KOMZIFTI launch generates $2.1M in first weeks; payers implement step edits… Kura Oncology Reports $0.92 Q4 Loss Even as KOMZIFTI Debuts With $2.1M in Sales 2 weeks ago Kura Oncology posted a $0.92 per share loss in Q4 2025 as KOMZIFTI generated $2.1M in debut sales, with payers…